IDEXX Laboratories Inc (IDXX)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 1,495,250 1,384,230 1,179,020 1,149,450 1,101,480 1,058,860 1,042,820 1,089,770 955,655 938,037 1,001,230 1,097,800 1,062,740 868,679 779,612 721,351 679,639 703,382 712,298 697,646
Total current liabilities US$ in thousands 951,547 970,193 883,859 1,065,630 1,235,800 1,189,940 1,166,550 971,341 763,579 633,849 651,809 620,662 582,761 526,841 540,584 846,241 725,337 626,627 618,909 689,619
Current ratio 1.57 1.43 1.33 1.08 0.89 0.89 0.89 1.12 1.25 1.48 1.54 1.77 1.82 1.65 1.44 0.85 0.94 1.12 1.15 1.01

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,495,250K ÷ $951,547K
= 1.57

The current ratio of Idexx Laboratories, Inc. has shown an improving trend over the past quarters, indicating a strengthening liquidity position. In Q4 2023, the current ratio stood at 1.57, the highest level among the reported quarters. This suggests that Idexx Laboratories has $1.57 in current assets available to cover each dollar of current liabilities, reflecting a healthy liquidity position.

The current ratio has been steadily increasing since Q1 2022, where it was at 1.12, showing consistent improvement in managing short-term obligations. The current ratio exceeding 1 indicates that Idexx Laboratories has more than enough current assets to meet its short-term liabilities, which is a positive indication of financial health and operational efficiency.

Overall, Idexx Laboratories' current ratio trend demonstrates a sound liquidity position, providing sufficient cushion to cover its short-term obligations as of Q4 2023.


Peer comparison

Dec 31, 2023